FAMU Names Ken Redda Vice President for Research
News Jun 07, 2014
Florida A&M University (FAMU) President Elmira Mangum, Ph.D., has appointed K. Ken Redda, Ph.D., vice president for research.
Redda, a professor of medicinal chemistry in the FAMU College of Pharmacy and Pharmaceutical Sciences, served as interim vice president for research since 2010. He previously served as the associate vice president for Research from 2004 to 2005 and currently serves as an activity leader for the Drug Discovery Core Facility, a component of the FAMU Research Center in Minority Institutions Program. His research focuses on the design and synthesis of nitrogen heterocycles as anti-inflammatory and anti-cancer agents.
During his 29-year tenure at FAMU, Redda has generated more than $36.5 million in research and training grant awards, garnered multiple patents and has received numerous awards for his outstanding achievements in teaching, research and service, including the prestigious Teaching Incentive Program Award, the Professorial Excellence Program Award and the Special Recognition Award for his exceptional contributions in the area of grantsmanship by former FAMU President Fred Gainous.
He was also named FAMU's “Advanced Teacher of the Year” in 2010 and the “Best Male Faculty Member" at the 2013 Historically Black Colleges and Universities (HBCU) Awards.
Redda, the author of “Cocaine, Marijuana, Designer Drugs: Chemistry, Pharmacology and Behavior,” has published approximately 60 scientific peer-reviewed and indexed papers and his research findings have been presented at nearly 100 national and international scientific meetings throughout the United States, North America, Europe, Africa and Asia.
Redda received his Ph.D. in medicinal chemistry from the Faculty of Pharmacy at the University of Alberta (Canada). He joined the FAMU faculty in 1985 as an associate professor of medicinal chemistry after serving as an assistant professor of medicinal chemistry at the University of Puerto Rico's College of Pharmacy in San Juan from 1980-1984.
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE